Boxer Capital, LLC’s Fate Therapeutics Inc Position
Does Boxer Capital, LLC own Fate Therapeutics Inc (FATE)? Not currently — the last reported position was 4.96M shares worth $17M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$17M
Q3 2024
Shares
4.96M
% of Portfolio
+0.85%
Quarters Held
12
position exited
Position History FATE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 4.96M | $17M | +0.85% |
| Q2 2024 | 8.22M | $27M | +1.42% |
| Q1 2024 | 8.22M | $60M | +2.98% |
| Q4 2023 | 500.0K | $2M | +0.09% |
| Q3 2023 | 500.0K | $1M | +0.06% |
| Q2 2023 | 500.0K | $2,380 | +0.11% |
| Q1 2023 | 500.0K | $2,850 | +0.14% |
| Q4 2022 | 1.25M | $13M | +0.66% |
| Q3 2022 | 350.0K | $8M | +0.44% |
| Q2 2022 | 500.0K | $12M | +0.78% |
| Q1 2022 | 500.0K | $19M | +1.00% |
| Q4 2021 | 500.0K | $29M | +1.14% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of FATE.